America's Next Top Model' Netflix docuseries directors tell all on chronicling sexual assault, racism and Tyra's fallout with the Jays ...

On Thursday, OpenAI released its first production AI model to run on non-Nvidia hardware, deploying the new GPT-5.3-Codex-Spark coding model on chips from Cerebras. The model delivers code at more ...

Starting this week, YouTube TV will start selling stripped-down bundles — packaged into genres including sports, news and entertainment — that cost less than its core $82.99/month plan. It’s not quite ...

Opening statements began in a trial claiming social media companies design addictive products that cause personal injury. Opening statements began in a trial claiming social media companies design ...

This is an online excerpt of the weekly AI & Business newsletter. Get more insights in your inbox each week by signing up here. Which AI model do you use now? An even more interesting question might ...

Anthropic, the makers of the popular and code-competent chatbot Claude, released a new model Thursday called Claude Opus 4.6. The company is doubling down on coding capabilities, claiming that the new ...

Tesla CEO Elon Musk said on an Wednesday earnings call that it would give the Model S and Model X electric vehicles an "honorable discharge" as the company moves away from its core EV business. Tesla ...

Howard Smith is a contributing Motley Fool stock market analyst covering technology and industrial stocks. Prior to The Motley Fool, Howard spent nearly 30 years supervising quality and operations in ...

Forbes contributors publish independent expert analyses and insights. Diane Omdahl is a Medicare expert who keeps her readers in the know. On December 23, the Centers for Medicare and Medicaid ...

Add Yahoo as a preferred source to see more of our stories on Google. A combination image shows an injection pen of Zepbound, Eli Lilly's weight loss drug, and boxes of Wegovy, made by Novo Nordisk.

Dec 23 (Reuters) - The U.S. Centers for Medicare and Medicaid Services on Tuesday unveiled a voluntary program to cover GLP-1 drugs for weight-loss and diabetes under Medicaid and Medicare Part D ...